Corporate Social Responsibility
RoseLabs is well aware of its accountability towards the society. Right from its corporate philosophy to its innovative formulations, all of its initiatives are oriented towards the betterment of humanity. RoseLabs has earmarked 2.5% of its net profits towards the fulfilment of its corporate social responsibility to translate words into actions.
At RoseLabs, we are vigilant on the impact of environmental pollution on human health. Particularly, contaminated needles and syringes pose a tremendous threat to human health. The failure to dispose medical waste safely may lead to hazards of infected products getting recycled and repackaged, which in turn leads to unsafe reuse. The World Health Organization (WHO) has expressed great concern over the issue, “Poor management of health care waste potentially exposes health care workers, waste handlers, patients and the community at large, to infection, toxic effects and injuries, and risks polluting the environment”.
Roselabs has taken upon itself to minimize the problem of toxic medical waste. Our research team is continuously making efforts to develop novel eco-friendly products which will considerably decrease medical waste, minimize risks to health workers and simultaneously reduce carbon footprint. It is our way of giving back to the society, by using science for human welfare and innovation for constructive purposes.
Why Roselabs novel drug delivery systems?
- Minimizes microbial contamination.
- Reduces dosage errors during medication
- Convenient and easy to use
- Available both in plastic and glass containers
- Prevents glass breakage and particulate formation